Y-Intercept (HK)’s HUTCHMED HCM Stock Holding History

Y-Intercept (HK)’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,461	Closed	-$227K	–	1454
2023 Q1	$227K	Buy	17,461 +4,039	+30%	+$66.2K	0.03%	898
2022 Q4	$198K	Buy	+13,422	New	+$147K	0.03%	836

Other funds holding HCM

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Y-Intercept (HK)'s HCM Position: Q2 2023 in Review

Y-Intercept (HK) sold out of HUTCHMED (HCM) in Q2 2023, closing a stake of 17,461 shares — an estimated $227K sold.

Y-Intercept (HK) first reported a position in HCM in Q4 2022 and held it in 2 quarters. The position peaked at $227K in Q1 2023. 70 funds tracked by Wall St. Rank hold HCM as of Q2 2023.

Y-Intercept (HK) reported no remaining HUTCHMED position as of Q2 2023 after selling out during the quarter.
Y-Intercept (HK) sold 17,461 HUTCHMED shares in Q2 2023, an estimated $227K.
Y-Intercept (HK) first reported a position in HUTCHMED in Q4 2022 and held it in 2 quarters.
Y-Intercept (HK)'s HUTCHMED position peaked at $227K in Q1 2023.
70 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2023.

Based on Y-Intercept (HK)'s 13F filing for Q2 2023, filed 14 Aug 2023.